These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


259 related items for PubMed ID: 23371873

  • 1. [Anticoagulation and atrial fibrillation].
    Simmers TA.
    Tijdschr Gerontol Geriatr; 2012 Dec; 43(6):308-12. PubMed ID: 23371873
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. New anticoagulants for the prevention of stroke in atrial fibrillation.
    Höchtl T, Huber K.
    Fundam Clin Pharmacol; 2012 Feb; 26(1):47-53. PubMed ID: 21883447
    [Abstract] [Full Text] [Related]

  • 8. New anticoagulants for atrial fibrillation.
    De Caterina R, Kristensen SD, Renda G.
    J Cardiovasc Med (Hagerstown); 2009 Jun; 10(6):446-53. PubMed ID: 19365276
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. New antithrombotics for atrial fibrillation.
    Bereznicki LR, Peterson GM.
    Cardiovasc Ther; 2010 Oct; 28(5):278-86. PubMed ID: 20645985
    [Abstract] [Full Text] [Related]

  • 11. Stroke prevention in atrial fibrillation patients.
    Marinigh R, Lip GY, Lane DA.
    Expert Opin Pharmacother; 2010 Oct; 11(14):2331-50. PubMed ID: 20718589
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ineligibility for anticoagulation in patients with atrial fibrillation.
    del Conde I, Halperin JL.
    Am J Med; 2013 Feb; 126(2):105-11. PubMed ID: 23331435
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Novel anticoagulants for stroke prevention in atrial fibrillation and chronic kidney disease.
    Turagam MK, Addepally NS, Velagapudi P.
    Expert Rev Cardiovasc Ther; 2013 Oct; 11(10):1297-9. PubMed ID: 24138517
    [Abstract] [Full Text] [Related]

  • 16. Impact of glomerular filtration estimate on bleeding risk in very old patients treated with vitamin K antagonists. Results of EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics).
    Poli D, Antonucci E, Zanazzi M, Grifoni E, Testa S, Ageno W, Palareti G.
    Thromb Haemost; 2012 Jun; 107(6):1100-6. PubMed ID: 22535516
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Benefits and risks of oral anticoagulation for stroke prevention in nonvalvular atrial fibrillation.
    Garcia DA.
    Thromb Res; 2012 Jan; 129(1):9-16. PubMed ID: 22018997
    [Abstract] [Full Text] [Related]

  • 19. Stroke prevention in elderly patients with atrial fibrillation.
    Lew SJ, Lim JK.
    Singapore Med J; 2002 Apr; 43(4):198-201. PubMed ID: 12188065
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.